One major unanswered question in apoptosis, an essential process in animal development and homeostasis, is how the cell-suicide program is executed in a highly coordinated fashion so that the dying cell is disassembled and removed swiftly without causing any deteriorating outcomes 1 . The cell death-execution process is activated by caspases, which are aspartate-specific cysteine proteases that cleave multiple substrates to orchestrate cellular disassembly, including chromosome fragmentation, nuclear-membrane breakdown and phagocytosis of apoptotic cells 1,2 . Numerous caspase substrates have been identified in mammals, and some are involved in cell-death execution in vivo 2 . For example, the PAK2 kinase is activated by caspase-3 cleavage, which is required for the fragmentation of dying cells into apoptotic bodies 3 . In C. elegans, many apoptosis regulators and executors are conserved 4 , including the CED-3 caspase and CED-3 activator CED-4 (homologous to the human caspase activator Apaf-1), both of which are essential for apoptosis in C. elegans. How CED-3 kills cells by proteolytic cleavage is poorly understood. Recently, the Dicer RNase (DCR-1) was found to be converted into a DNase upon CED-3 cleavage during apoptosis, to initiate apoptotic chromosome fragmentation 5 . Similarly, CED-3 cleavage of the mitochondrial fission protein DRP-1 and the multipass transmembrane protein CED-8 generates C-terminal cleavage products that promote mitochondria elimination and phosphatidylserine externalization, respectively, in apoptotic cells 6,7 . Thus, CED-3 cleavage of DCR-1, DRP-1 and CED-8 activates three different cell-disassembly events that facilitate cell killing. In this study, we report a new CED-3 substrate, CNT-1, whose cleavage by CED-3 activates an N-terminal cleavage product, truncated CNT-1 (tCNT-1), that promotes apoptosis by suppressing the AKT prosurvival activity.
RESULTS

CNT-1 promotes apoptosis downstream of CED-3
To identify genes encoding proteins acting downstream of CED-3 to kill cells, we performed a genetic screen to isolate suppressors of ectopic neuronal death induced by activated CED-3 (acCED-3) 35 and isolated a recessive mutation, sm8, which defines a new gene cps-2 (CED-3 protease suppressor) on linkage group (LG) II (Online Methods).
We investigated whether cps-2 affects apoptosis by examining embryonic cell death in cps-2(sm8) animals. Compared with wild type N2 embryos, cps-2(sm8) embryos had fewer apoptotic cell corpses in the early stages of embryogenesis (comma and 1.5-fold stages) and more cell corpses in later stages (Fig. 1a) , displaying a characteristic delay-of-cell-death phenotype observed in mutants defective in genes encoding proteins acting downstream of CED- 3 (refs. 7,35-37) . Three-point mapping and single-nucleotide polymorphism (SNP) mapping placed cps-2(sm8) at a position of 12103628 bp on LGII (Fig. 1b) . Because there are no available fosmid or cosmid clones in this region for transformation rescue experiments, we performed an RNA interference (RNAi) screen on nine candidate genes in this region and found that RNAi knockdown of cnt-1 caused a similar delay-of-cell-death defect ( Supplementary Table 1 ). We then introduced into cps-2(sm8) animals a cnt-1 minigene containing a fulllength cnt-1 cDNA fused to 1,944 bp of the cnt-1 promoter and found that it rescued the cps-2(sm8) defect ( Fig. 1b and Supplementary  Fig. 1a ). Moreover, an existing cnt-1-deletion mutation (tm2313) caused a similar delay-of-cell-death defect and failed to complement cps-2(sm8) (Fig. 1a) , thus indicating that tm2313 and sm8 are allelic. Sequencing analysis of cps-2(sm8) animals revealed a nucleotide deletion at 927 bp upstream from the cnt-1 translational start but no mutation in the coding region of cnt-1 and the 1,031-bp 3′ untranslated region. Because a cnt-1 minigene carrying this nucleotide deletion failed to rescue the cell-death defect in cps-2(sm8) animals ( Fig. 1b  and Supplementary Fig. 1a ) and because neither cnt-1 mRNA nor CNT-1 protein was detectable in cps-2(sm8) animals ( Supplementary  Fig. 1b,c) , sm8 probably disrupts a cis element important for cnt-1 expression. These results indicate that cps-2 is cnt-1. cnt-1(tm2313) was thus used in all subsequent experiments.
We examined whether delay of cell death caused by cnt-1(tm2313) results in survival of cells that normally die, yielding extra 'undead' cells in the anterior pharynxes of mutant animals 35 . Like wild-type animals, cnt-1(tm2313) animals had few extra undead cells ( Supplementary Table 2 ). However, in sensitized backgrounds such as in animals weakly defective in ced-3 and ced-4, cnt-1(tm2313) significantly increased the numbers of extra cells observed in these weak-celldeath mutants, thus indicating that cnt-1 promotes apoptosis.
Because sm8 inhibits acCED-3-induced neuronal death, we examined whether CNT-1 functions downstream of CED-3, using an integrated transgene (smIs111) expressing acCED-3 from the egl-1 promoter 38 . The cell death-initiating EGL-1 functions upstream of CED-3 to induce apoptosis and is mainly expressed in dying cells 39 . When we placed smIs111 in the ced-4(n1162) mutant, in which almost all physiological cell death is blocked, acCED-3 still induced ectopic cell death (Fig. 1c) . cnt-1(tm2313) significantly reduced the number of ectopic deaths in smIs111; ced-4(n1162) embryos, thus indicating that CNT-1 is likely to act downstream of CED-3 to promote apoptosis.
CNT-1 is cleaved sequentially at two sites by CED-3
Given that CNT-1 acts downstream of CED-3, we tested whether CNT-1 is a substrate of CED-3 protease. We incubated an 35 S-methioninelabeled glutathione S-transferase (GST) fusion of the longer CNT-1 isoform, GST-CNT-1a, with CED-3 and found that it was cleaved by CED-3 to yield two species of approximately 68 and 24 kDa ( Fig. 2a) . Because GST-CNT-1a is 116 kDa, this cleavage pattern suggests that the 24-kDa species might contain two cleavage products of similar sizes and that CNT-1a is cleaved at two different sites. From the consensus CED-3-cleavage sites (DXXD, with X representing any amino acid) 40 , we identified three potential CED-3-cleavage sites: Asp382 (DSVD), Asp508 (DSID) and Asp609 (DVQD). We then generated aspartate-to-glutamate substitutions in each potential cleavage site (D1, D2 and D3) and tested CED-3 cleavage of the mutant proteins. The D1E mutation completely abolished cleavage of CNT-1a by CED-3 ( Fig. 2a) , thus suggesting that D1 is required for CED-3 cleavage. The D2E mutation did not alter the cleavage pattern ( Fig. 2a) , a result indicating that D2 is not a CED-3-cleavage site in vitro. The D3E mutation abolished the 24-kDa species and instead produced a new 47-kDa band along with the 68-kDa band ( Fig. 2a) , thus confirming that CED-3 cleavage at D3 generates two cleavage products of similar sizes (23 and 24 kDa). Because D1E also blocked cleavage at the D3 site, CED-3 cleavage at the D1 site is required for cleavage at the D3 site. In CNT-1b-a shorter isoform of CNT-1 that Figure 1 Cloning and characterization of cps-2. (a) Embryonic cell corpses counted in animals with the indicated genotypes. (b) Mapping and cloning of cps-2. Top, genetic map with two genetic markers (dpy-10 and rol-1) and three SNPs (pkP2069, CE2-196 and Y43F11A [1] ) used for mapping cps-2(sm8). Numbers below are the numbers of recombination events (out of 105 total) that occurred between two genetic markers and three SNPs. Bottom, the cnt-1 coding region, the sm8 mutation, the tm2313 deletion and the results of rescue of the cps-2(sm8) mutant by the P cnt-1 CNT-1aø3×Flag and P cnt-1(sm8) CNT-1aø3×Flag constructs. Three independent transgenic arrays (numbers inside parentheses) were examined for each rescue experiment, and the number of arrays that rescued the cell-death defect of cps-2(sm8) is indicated. ∆A indicates the A nucleotide deleted in cps-2(sm8). (c) Embryonic cell corpses counted in animals with the indicated genotypes. In a and c, average number of cell corpses ±s.d.
(n = 15 embryos at each stage) are shown. *P < 0.001; **P < 0.05 by two-way ANOVA followed by Bonferroni comparison. 261  D1  D2  D3  K284   CED-3  CED-3   826  Ank repeat  Arf GAP  PH  GST   68 kDa   382   383  609  610  826   24 kDa  23 kDa   47 kDa   116 kDa   tCNT-1a 1   CNT-1a F2  CNT-1a F3 GST-CNT-1a )  150   68 kDa  47 kDa   24 kDa  23 kDa   100  75  50  37 25 20 has the same 564-amino acid C terminus, including a PH domain, but a different 177-residue N-terminal sequence (Fig. 2b) -we found three identical CED-3-cleavage sites (Asp298, Asp424 and Asp525). We observed similar CED-3-cleavage patterns with GST-CNT-1b and GST-CNT-1b mutants carrying D1E, D2E or D3E ( Fig. 2b) . These data indicate that D1 is the primary CED-3-cleavage site in CNT-1 and is required for subsequent CED-3 cleavage at D3. To examine whether CNT-1 is a CED-3 substrate in vivo, we probed for CNT-1-cleavage products in worm lysates by using an antibody raised against the N-terminal cleavage product of CNT-1b (tCNT-1b), which recognizes recombinant tCNT-1b and tCNT-1a ( Supplementary Fig. 1d ). In wild-type animals, we detected two bands consistent with the sizes of full-length CNT-1a and CNT-1b, which were absent in the cnt-1(tm2313) mutant (Fig. 2c) . The observed absence of cleaved CNT-1 products is because little apoptosis occurs in wild-type embryos. In animals carrying an integrated transgene (smIs82) that induces global expression of death initiator EGL-1 and widespread apoptosis under the control of heat-shock promoters (P hsp EGL-1) 6 , the same two bands were present before heatshock treatment ( Fig. 2c) . After heat-shock treatment, the intensity of these two bands was reduced, and two smaller bands consistent with the sizes of tCNT-1a and tCNT-1b appeared. The appearance of the tCNT-1a and tCNT-1b bands was CED-3 dependent, because a ced-3(n717) lf mutation abolished these two bands in smIs82 animals. Therefore, CNT-1 is cleaved by CED-3 in C. elegans.
Cleavage of CNT-1 activates tCNT-1 proapoptotic activity
We determined whether CNT-1 cleavage by CED-3 is important for apoptosis ( Fig. 3) . Expression of CNT-1a or CNT-1b from a globally active dpy-30 promoter (P dpy-30 ) fully rescued the delay-of-cell-death defect in cnt-1(tm2313) animals ( Fig. 3a and Supplementary Fig. 2a ). However, P dpy-30 CNT-1a(D1E) and P dpy-30 CNT-1b(D1E), expressing CNT-1 mutants resistant to CED-3 cleavage, did not rescue the cnt-1(tm2313) mutant ( Fig. 3b and Supplementary Fig. 2b ), thus indicating that cleavage of CNT-1 by CED-3 is critical for its proapoptotic function. Expression of tCNT-1a or tCNT-1b at 20% of the endogenous CNT-1 level ( Supplementary Fig. 2c,d ) led to increased cell death in most embryonic stages compared to that in wild type and cnt-1(tm2313) embryos ( Fig. 3c and Supplementary Fig. 2e ). The increased numbers of cell corpses observed in animals carrying P dpy-30 tCNT-1a or P dpy-30 tCNT-1b were due to ectopic cell death, because some pharyngeal cells that normally live were randomly lost in transgenic larvae ( Supplementary Table 3 ). In comparison, coexpression of the other two CNT-1a CED-3-cleavage fragments, CNT-1a F2 and CNT-1a F3 ( Fig. 2a) , did not induce ectopic cell death or rescue the cnt-1(tm2313) mutant ( Fig. 3d) , whereas coexpression of all three CED-3-cleavage products did ( Supplementary Fig. 2f ).
These results indicate that tCNT-1, activated by CED-3 cleavage, is responsible for CNT-1's proapoptotic activity.
CNT-1 promotes cell death by inhibiting the AKT pathway
Because the only recognizable motif in tCNT-1 is the PH domain ( Fig. 2) , a potential PI-binding domain 41 , and because one of the PI species, PIP 3 , activates AKT kinases (also containing a PH domain) to promote cell survival 8, 9 , we asked whether C. elegans AKT kinases participate in regulating apoptosis and genetically interact with cnt-1. An activating mutation in akt-1, akt-1(mg144gf) 22 , caused a delay-of-cell-death defect similar to that of the cnt-1(tm2313) mutant 35 S-methioninelabeled GST-CNT-1a and its mutant derivatives incubated with or without CED-3, resolved by 15% SDS-PAGE gel. CED-3-cleavage products are indicated by arrows. Right, schematic diagram of GST-CNT-1a and sizes of the CED-3-cleavage products (tCNT-1a, CNT-1a F2 and CNT-1a F3). Three predicted CED-3-cleavage sites are indicated with arrows. The black box at the N terminus represents the region that is different from CNT-1b. The lysine residue in the PH domain (K284) critical for lipid binding is indicated with an asterisk. (b) CNT-1b cleavage by CED-3. Left, GST-CNT-1b and its mutant derivatives synthesized, labeled, digested with CED-3 and resolved on SDS-PAGE as in a. Right, schematic diagram of GST-CNT-1b with the sizes of the CED-3-cleavage products indicated. The gray box at the N terminus represents the region that is different from CNT-1a. Supplementary Fig. 1e .) Right, schematic diagram of CNT-1a, tCNT-1a, CNT-1b and tCNT-1b and their sizes. Ank, ankyrin; GAP, GTPase-activating protein; MW, molecular weight. npg a r t i c l e s ( Fig. 4a) . Combination of cnt-1(tm2313) and akt-1(mg144gf) did not enhance this phenotype, thus suggesting that AKT-1 and CNT-1 function in the same pathway. Because the ced-3(n2438); akt-1(mg144gf) double mutant had more extra undead cells than ced-3(n2438) or akt-1(mg144gf) single mutants ( Supplementary Table 4 ), this suggests that AKT-1 inhibits cell death. Epistasis analysis with animals carrying a P dpy-30 tCNT-1a transgene showed that akt-1(mg144gf) completely blocked ectopic cell death induced by P dpy-30 tCNT-1a ( Fig. 4b) , a result indicating that AKT-1 probably acts downstream of CNT-1 to inhibit cell death. In agreement with this result, akt-1(mg144gf) suppressed ectopic cell death induced by smIs111, a transgene expressing acCED-3, to the same extent as cnt-1(tm2313) (Fig. 1c) , thus indicating that AKT-1 can act downstream of CED-3 to promote cell survival.
We also examined animals carrying a lf mutation in akt-1, akt-2 or sgk-1, encoding three AKT kinases acting in parallel in the IIS pathway 22, 23 . akt-1(tm399), akt-2(tm1075) and sgk-1(ok538) each did not cause a detectable cell death defect, whereas all three combinations of double mutations and the triple mutation combination caused increased cell death throughout embryogenesis ( Supplementary Fig. 3a ), thus indicating that the presence of at least two AKT and SGK kinases is important for cell survival. Because cnt-1(tm2313) failed to suppress ectopic cell death in the triple mutant ( Fig. 4c and Supplementary Table 5 ), these results suggest that CNT-1 functions upstream of AKT-1, AKT-2 and SGK-1 to promote cell death.
AKT kinases phosphorylate proteins to transduce signals in various pathways 22, 42, 43 . To examine whether the kinase activity of AKT is important for its antiapoptotic activity, we expressed kinase-defective mutants of AKT-1 and AKT-2, AKT-1(K222M) and AKT-2(K209M), in the akt-1(tm399); akt-2(tm1075) mutant 22 . Expression of wild-type AKT-1 or AKT-2 rescued the increased-cell-death phenotype of the akt-1(tm399); akt-2(tm1075) mutant, whereas expression of AKT-1 (K222M) or AKT-2(K209M) did not ( Supplementary Fig. 4a,b) , thus indicating that the kinase activity of AKT is required for its prosurvival function.
A key substrate of AKT kinases in the IIS pathway is DAF-16, a homolog of the FOXO transcriptional factor 24, 25, 42 . A daf-16 lf mutation, mu86, caused a delay-of-cell-death defect similar to that of cnt-1(tm2313) or akt-1(mg144gf) animals but did not enhance their cell-death defects (Supplementary Fig. 3b,c) , thus indicating that DAF-16, AKT-1 and CNT-1 function in the same pathway to affect apoptosis. Moreover, daf-16(mu86) fully suppressed ectopic cell death induced by tCNT-1a (Supplementary Fig. 3d) and increased the number of extra undead cells in ced-3(n2438) animals (Supplementary Table 4 ), suggesting that DAF-16 acts downstream of CNT-1 to promote cell death.
CNT-1 acts downstream of PI3K to promote cell death C. elegans AKT kinases are activated by PIP 3 and therefore are regulated by AGE-1, a PI3K that phosphorylates PIP 2 to generate PIP 3 (refs. 19,20) . An age-1(mg44) lf mutation caused an increased-cell-death phenotype similar to that of akt-1(tm399); akt-2(tm1075) sgk-1(ok538) animals ( Fig. 4c,d) but did not enhance the increased-celldeath phenotype caused by P dpy-30 tCNT-1a ( Supplementary Fig. 3e) , thus suggesting that AGE-1 inhibits and tCNT-1 promotes apoptosis in the same pathway. Conversely from what we observed with the akt-1(lf); akt-2(lf) sgk-1(lf) triple mutant ( Fig. 4c) , cnt-1(tm2313) blocked both the increased cell death and the missing-cell phenotypes caused by age-1(mg44) ( Fig. 4d and Supplementary Table 5 ), thus indicating that CNT-1 probably acts downstream of AGE-1 to promote apoptosis. PIP 3 is dephosphorylated and converted to PIP 2 by the PTEN phosphatase 8, 9 , which is encoded by daf-18 in C. elegans [28] [29] [30] [31] . The daf-18(e1375) lf mutation caused a delay-of-cell-death phenotype similar to that of cnt-1(tm2313) animals ( Fig. 4e) and did not exacerbate the cnt-1(tm2313) cell-death defect, thus suggesting that DAF-18 and CNT-1 act in the same pathway. daf-18(e1375) also increased the number of extra cells in ced-3(n2438) animals ( Supplementary Table 4 ). daf-18(e1375), however, did not block ectopic cell death induced by tCNT-1a ( Fig. 4f) , a result indicating that DAF-18 acts upstream of, or in parallel to, CNT-1 to promote cell 
Cleavage of CNT-1 activates its PI binding
Given that AGE-1 activates AKT kinases through PIP 3 , and DAF-18 inactivates this pathway through dephosphorylation of PIP 3 , we hypothesized that tCNT-1, with a PH domain, promotes cell death by interfering with the binding of PIP 3 by AKT kinases. We examined whether tCNT-1 binds PIP 3 by using an in vitro lipid binding assay. 35 S-methionine-labeled GST-CNT-1a on its own did not bind any lipid but showed strong binding to PIP, PIP 2 and PIP 3 and weak binding to phosphatidic acid and cardiolipin after pretreatment with CED-3 ( Fig. 5a) .
GST-tCNT-1a displayed an identical lipid binding pattern to that of CED-3-treated GST-CNT-1a (Fig. 5a) , and so did GST-CNT-1b pretreated with CED-3 and GST-tCNT-1b ( Fig. 5a) . When we altered one of the highly conserved PI-binding lysine residues in the PH domain of CNT-1a (K284A) 44 , neither CNT-1a(K284A) pretreated with CED-3 nor tCNT-1a(K284A) showed any lipid binding activity (Fig. 5a) . Moreover, expression of CNT-1a(K284A) or tCNT-1a(K284A) in cnt-1(tm2313) animals did not rescue the cell-death defect or cause ectopic cell death (Fig. 3e,f) . Because the K284A mutation did not alter the expression levels of CNT-1a proteins in vitro or in vivo (Supplementary Fig. 5) , these results indicate that the PH domain is required for tCNT-1 to acquire PI binding after CED-3 cleavage and to promote apoptosis.
tCNT-1 blocks PIP 3 binding by AKT and SGK kinases
We tested whether tCNT-1 interferes with binding of AKT and SGK kinases to PIP 3 (refs. [21] [22] [23] . 35 S-methionine-labeled AKT-1 alone bound strongly to PIP 3 and weakly to cardiolipin, and this binding was not affected by addition of unlabeled GST-CNT-1a or GST-CNT-1b ( Fig. 5b) . Addition of GST-CNT-1a or GST-CNT-1b pretreated with CED-3 completely blocked PIP 3 binding by AKT-1 (Fig. 5b) , whereas incubation of AKT-1 with CED-3 did not alter AKT-1 lipid binding (Fig. 5b) . Likewise, both AKT-2 and SGK-1 bound strongly to PIP 3 , and this binding was blocked by GST-CNT-1a pretreated with CED-3 ( Fig. 5c) . To probe how tCNT-1 inhibits PIP 3 binding by AKT-1, we compared their PIP 3 binding affinity. We first determined the concentrations of 35 S-methionine-labeled GST-tCNT-1a and AKT-1 synthesized in rabbit reticulocyte lysate (RRL) by comparing them with known concentrations of recombinant GST-tCNT-1a and AKT-1 proteins, which were purified from bacteria and showed no lipid binding activity (Fig. 6a) .
Labeled GST-tCNT-1a and hexahistidine (His 6 )-tagged AKT-1 displayed comparable radioactive-signal intensity at the same concentrations ( Fig. 6b) . GST-tCNT-1a displayed strong PIP 3 binding at 0.04 nM, weak binding at 0.004 nM and no binding at 0.0004 nM (Fig. 6c) . By contrast, AKT-1 showed strong PIP 3 binding at 4 nM, weak binding at 0.4 nM and no binding at 0.04 nM (Fig. 6c) , results indicating that tCNT-1a binds PIP 3 with an affinity two orders of magnitude higher than that of AKT-1. Because the expression level of CNT-1 in C. elegans is approximately 70% higher than that of AKT-1 (Supplementary Fig. 6 ), the combination of higher CNT-1 concentrations and much higher binding affinity to PIP3 than those of AKT-1 allows tCNT-1 to block PIP 3 binding by AKT kinases and thus block their activation.
tCNT-1 translocates to the plasma membrane upon CED-3 cleavage
Several proteins containing the PH domain translocate from the cytosol to the plasma membrane via a PIP 3 -mediated mechanism [45] [46] [47] . We analyzed the subcellular localization of CNT-1 by using an antibody raised against tCNT-1b ( Supplementary Fig. 1d ). CNT-1 localized in the cytoplasm of all cells in wild-type embryos (Fig. 7a ) but was not detectable in cnt-1(tm2313) embryos (Fig. 7b) , thus demonstrating the specificity of the antibody. In smIs82 (P hsp EGL-1) a r t i c l e s embryos in which we induced global apoptosis and widespread CED-3 activation through heat-shock treatment, we observed CNT-1 staining on the plasma membranes of all cells in addition to staining in the cytoplasm ( Fig. 7d and Supplementary Fig. 7c,d) , results indicating that a portion of CNT-1 translocated from the cytosol to the plasma membrane upon apoptosis activation. By contrast, in smIs82 embryos without heat-shock treatment or in smIs82; ced-3(n717) embryos with heat-shock treatment, CNT-1 remained in the cytoplasm (Fig. 7c,e and Supplementary  Fig. 7a,b ,e,f), thus indicating that CNT-1 translocation from the cytosol to the plasma membrane is dependent on apoptosis and CED-3. In cnt-1(tm2313); smIs82 embryos expressing CNT-1a(D1E), the CED-3-uncleavable form of CNT-1a, CNT-1a(D1E) did not translocate to the plasma membrane after heat-shock treatment (Supplementary Fig. 7g-i) . In contrast, in cnt-1(tm2313); smIs82 embryos expressing CNT-1a, we observed CNT-1a on plasma membranes after heat-shock treatment (Supplementary Fig. 7j-l) .
These results confirm that CED-3 cleavage is required for CNT-1 translocation to the plasma membrane during apoptosis. Consistently with this, loss of cnt-1 partially suppressed and e xpression of tCNT-1a enhanced ectopic cell death induced by smIs82 (Supplementary Note and Supplementary Fig. 4c,d) , thus providing further support to the finding that cleavage of CNT-1 and activation of tCNT-1 is an important downstream event of CED-3 activation and apoptosis. 
tCNT-1 inhibits association of AKT-1 with the plasma membrane
AKT-1 also contains a PH domain, and its human homolog translocates to the plasma membrane through binding to PIP 3 (ref. 48) . Given the limited amount of PIP 3 on the plasma membrane, the higher concentration of CNT-1 than AKT-1 in vivo and the much-stronger PIP 3 binding affinity of tCNT-1 than AKT-1, we examined whether tCNT-1 blocks AKT-1 translocation to the plasma membrane. We fused the first 180 residues of AKT-1, including its PH domain (residues 15-118), to GFP and expressed it from the sur-5 gene promoter (P sur-5 AKT-1-PHøGFP). In wild-type embryos carrying P sur-5 AKT-1-PHøGFP, GFP was diffuse within the cells (Fig. 7f) . When we crossed this transgene into daf-18(e1375) animals, which are deficient in converting PIP 3 to PIP 2 and thus have elevated levels of PIP 3 in the plasma membrane, we saw bright GFP signals on the plasma membrane, thus suggesting that AKT-1-PHøGFP translocated to the plasma membrane through binding to PIP 3 (Fig. 7g) . Expression of tCNT-1a abolished AKT-1-PHøGFP localization to the plasma membrane in daf-18(e1375) embryos (Fig. 7h) , thus indicating that tCNT-1 inhibited association of AKT-1 with the plasma membrane. Similarly, in smIs82; daf-18(e1375) animals carrying P sur-5 AKT-1-PHøGFP, some AKT-1-PHøGFP localized to the plasma membrane in the absence of heat-shock treatment (Fig. 7i) . After heat-shock treatment, AKT-1-PHøGFP disappeared from the plasma membrane (Fig. 7j) , a result indicating that endogenous tCNT-1 induced by smIs82 is sufficient to block AKT-1 association with the plasma membrane and thus block AKT-1 activation and function.
DISCUSSION
The physiological relevance of caspase substrates is an under-studied area that limits the understanding of apoptosis. We have identified multiple components acting downstream of CED-3 to promote apoptosis, using a sensitized CED-3 protease suppressor (cps) screen 35 . The cell-death defects of each cps mutant are mild or undetectable because multiple pathways downstream of CED-3 act in parallel to kill the cell [5] [6] [7] 35 . In this study, we characterized one of the cps genes, cps-2 (cnt-1), whose inactivation delays cell death and suppresses apoptosis in sensitized genetic backgrounds. Importantly, CNT-1 is a substrate of CED-3 both in vitro and in vivo. A mutation blocking CNT-1 cleavage by CED-3 abolishes its proapoptotic activity, whereas tCNT-1 alone is sufficient to induce apoptosis. These results establish that CNT-1 is an in vivo CED-3 target.
Despite containing a PH domain, a potential PI-binding motif, CNT-1 does not bind any phospholipids in vitro or associate with the plasma membrane in vivo. Upon activation by CED-3 cleavage during apoptosis, tCNT-1 acquires strong binding to PIs and translocates to the plasma membrane, where it outcompetes AKT kinases for PIP 3 binding to block recruitment and activation of AKT kinases at the plasma membrane, thereby inactivating the AKT survival pathway to accelerate cell killing (Fig. 8) . Therefore, CED-3 activates a downstream death-execution event by cleaving CNT-1, which then inactivates the AKT cell-survival pathway. Our study elucidates a previously unknown regulatory link between cell-death execution and cell-survival signaling.
Given the critical roles of the AKT kinases in cell growth, survival and metabolism, the activities of AKT kinases are tightly regulated at several different levels 9, 14 . Association of AKT with PIP 3 generated by PI3K at the plasma membrane is the critical first step. This is followed by sequential phosphorylation of AKT by PDK1 and mTORC2, leading to full activation of AKT. At each step, negative regulators are in place to fine-tune the level of AKT activation. The PTEN phosphatase converts PIP 3 back to PIP 2 , reducing or blocking AKT activation 49, 50 . Dephosphorylation of AKT by phosphatases, including protein phosphatase 2A and phosphatase PHLPP, also reduces or blocks AKT activation [51] [52] [53] [54] . In this study, we report a new mechanism that could rapidly npg a r t i c l e s shut down AKT at the level of PIP 3 binding and plasma-membrane recruitment, through proteolytic activation of a PH-containing protein to generate a competing PI-binding activity. Given the presence of hundreds of PH-domain proteins with unknown functions in eukaryotes 41 , this could be a general and conserved mechanism for regulating membrane-associated cell signaling or activity. There are several potential human CNT-1 homologs, ACAP1, ACAP2 and ACAP3, but none has been reported to have a role in apoptosis. It will be interesting to investigate whether these ACAP proteins might act like CNT-1 to inhibit AKT survival signaling in humans. AKT kinases and PI3K are required for the IIS pathway in C. elegans. Inactivation of these genes increases life span and stress resistance 32, 33 . Interestingly, loss of cnt-1 does not affect these two processes (Supplementary Fig. 8 ), thus indicating that CNT-1 is an apoptosis-specific inhibitor of the PI3K-AKT pathway. AKT is a major drug target in treating cancer; however, clinical development of AKT inhibitors has been restricted by AKT's involvement in multiple important cellular events, which inevitably will lead to numerous on-target or off-target side effects 9, 14, 55 . Targeted inactivation of AKT in cancer cells to induce apoptosis through a CNT-1-like mechanism could present a new therapeutic strategy when combined with other anticancer therapies.
METHODS
Methods and any associated references are available in the online version of the paper.
ONLINE METHODS
Strains and culture conditions. C. elegans strains were maintained with standard procedures 56 . The following alleles were used in the genetic analyses. For LGI: daf-16(mu86), ced-1(e1735), smIs13 and smIs111. For LGII: dpy-10(e128), age-1(mg44), cnt-1(tm2313), cps-2(sm8) and rol-1(e91). For LGIII: daf-2(e1370), ced-4(n1162, n2273) and smIs82. For LGIV: daf-18(e1375), ced-3(n717, n2438) and dpy-4(e1166). For LGV: akt-1(mg144gf, tm399) and him-5(e1490); LGX, akt-2(tm1075) and sgk-1(ok538). -2(sm8) mutation. Ethyl methane sulfonate (EMS) mutagenesis was performed on animals carrying an integrated transgene (smIs1) containing both P mec-7 acCED-3 and P mec-3 GFP 35 . P mec-7 acCED-3 drives acCED-3 expression in six mechanosensory neurons and also drives the ectopic death of these nonessential neurons, which were also labeled by GFP (P mec-3 GFP). Progeny of the mutagenized animals were screened for mutants with increased survival of the fluorescent mechanosensory neurons. From a screen of 3,000 mutagenized haploid genomes, we isolated several recessive mutations, including sm8, which defined a new gene, cps-2 (CED-3 protease suppressor) on linkage group (LG) II. For the complementation-test result shown in Figure 1a , the complete genotype of cps-2(sm8)/cnt-1(tm2313) is smIs13/+; cps-2(sm8)/cnt-1(tm2313); him-5(e1490)/+. smIs13 is an integrated line of P sur-5 SUR-5øGFP.
Isolation of the cps
Quantification of cell corpses and extra cells. The number of cell corpses in liv-
ing embryos and the number of extra cells in the anterior pharynxes of L4 larvae were scored with Nomarski optics as described previously 35 .
CNT-1 antibody. Amino acids 1-298 of CNT-1b (tCNT-1b) fused with glutathione S-transferase (GST) were expressed in Escherichia coli strain BL21(DE3) and affinity purified from the soluble fraction of the bacterial lysate with glutathione Sepharose 4B beads (GE Healthcare). Rats were immunized with purified GST-tCNT-1b proteins (Spring Valley Laboratories). CNT-1 antibodies were affinity purified (Spring Valley Laboratories) from terminal bleeds with purified GST-tCNT-1a proteins as described previously 57 .
Immunoblotting analysis. C. elegans embryos were harvested with M9, centrifuged at 500g to remove bacteria, and then sonicated in PBS buffer. After centrifugation at 25,400g to remove debris, 2× SDS loading buffer was added, and samples were heated at 95 °C for 3 min. The samples were resolved with 15% SDS-PAGE and transferred to PVDF membrane (Millipore). The membrane was first blocked with 5% nonfat dry milk in PBS-T (PBS plus 0.1% Tween 20) and washed two times with PBS-T for 5 min each. The membrane was then incubated with affinity-purified anti-CNT-1 antibody in 1:1,000 dilution for 1 h at room temperature and washed three times with PBS-T for 5 min each. It was then incubated with HRP-conjugated goat anti-rat IgG antibody (Jackson Immunoresearch, cat. no. 112-035-003; validation provided on the manufacturer's website) at 1:2,000 dilution for 1 h at room temperature, washed three times with PBS-T, and detected with enhanced chemiluminescent substrate (Pierce). For α-tubulin immunoblotting, anti-α-tubulin antibody (Developmental Studies Hybridoma Bank, cat. no. AA4.3; validation provided on the manufacturer's website) was used at 1:5,000 dilution, and HRP-conjugated goat anti-mouse IgG antibody (Jackson Immunoresearch, cat. no. 115-035-003; validation provided on the manufacturer's website) was used at 1:3,000 dilution. For anti-GST and anti-His 6 immunoblotting, a mouse anti-GST antibody (Santa Cruz Laboratory, cat. no. sc-138; validation provided on the manufacturer's website) or a rabbit anti-His 6 antibody (Santa Cruz Laboratory, cat. no. sc-803; validation provided on the manufacturer's website) was used at 1:2,000 dilution with an HRPconjugated goat anti-mouse IgG antibody or an HRP-conjugated goat anti-rabbit IgG antibody (Jackson Immunoresearch, cat. no. 111-035-003; validation provided on the manufacturer's website) at 1:3,000 dilution. For anti-AKT-1 immunoblotting, an affinity-purified goat anti-AKT-1 antibody (Bethyl Laboratories) 58 was used at 1:10,000 dilution with an HRP-conjugated donkey anti-goat IgG antibody (Jackson Immunoresearch, cat. no. 705-035-003; validation provided on the manufacturer's website) at 1:10,000 dilution.
Heat-shock experiments. The heat-shock experiments were carried out as described previously 5 .
CED-3-cleavage assay. CED-3 protease assays were done as described previously 40 . Briefly, proteins of interest were synthesized and labeled with 35 S-methionine with TNT Transcription and Translation coupled system (Promega) and incubated with or without 5 ng of purified CED-3 at 30 °C for 1 h. The reactions were then resolved by 15% SDS-PAGE gel and subjected to autoradiography.
Lipid binding assay. Various CNT-1 proteins were synthesized and labeled with 35 S-methionine with the TNT system and incubated with or without purified CED-3 as described above. The membrane strip containing various lipids (Echelon Biosciences) was blocked in 3% fatty acid-free bovine serum albumin (Sigma) in PBS-T (PBS plus 0.01% Tween 20) for 1 h and washed three times with PBS-T. The membrane strip was then incubated with 2 µl of the reticulocyte lysate containing the protein of interest at 1:1,000 dilution in PBS-T for 1 h at room temperature. After being washed three times with PBS-T, the membrane strip was subjected to autoradiography. For the PIP 3 competition assay, AKT-1, AKT-2 and SGK-1 were synthesized and labeled with 35 S-methionine, whereas GST-CNT-1 was synthesized with unlabeled methionine. After GST-CNT-1 was pretreated with CED-3, the lysate containing 35 S-methionine-labeled AKT-1 (20 µl) and the lysate containing unlabeled GST-CNT-1 (2 µl) were added to the membrane strip in 2 ml of PBS-T at the same time.
Determination of in vitro-synthesized protein concentrations. The concentrations of GST-tCNT-1a and AKT-1-His 6 synthesized in rabbit reticulocyte lysate (also labeled by 35 S-methionine) were determined by the immunoblotting analysis comparing the signal intensity of these proteins with that of recombinant GST-tCNT-1a (12 µg/ml) or AKT-1-His 6 (20 µg/ml) purified from bacteria. Recombinant GST-tCNT-1a or AKT-1-His 6 purified from bacteria did not show any lipid binding activity, probably owing to misfolding of the proteins. Briefly, 5.1 µl of GST-tCNT-1a or 2.9 µl of AKT-1-His 6 synthesized in rabbit reticulocyte lysate (*RRL) or 1 pmol of GST-tCNT-1a or AKT-1-His 6 purified from bacteria were resolved by 15% SDS-PAGE and subjected to immunoblotting analysis with an anti-GST or an anti-His 6 antibody as described above. Because the amounts of two GST-tCNT-1a proteins are comparable, the concentration of GST-tCNT-1a from RRL is approximately 196 nM. Because the amounts of two AKT-1-His 6 proteins are also comparable, the concentration of AKT-1-His 6 from RRL is approximately 345 nM.
Transgenic worms. Transgenic animals were generated as described previously 59 . P cnt-1 CNT-1aø3×Flag or P cnt-1(sm8) CNT-1aø3×Flag was injected into cps-2(sm8) animals at 20 µg/ml along with the pTG96 plasmid (at 20 µg/ml) as a co-injection marker. The pTG96 plasmid contains a sur-5øgfp translational fusion that is expressed in all somatic cells at most developmental stages 60 . P dpy-30 CNT-1a, P dpy-30 CNT-1b, P dpy-30 CNT-1a(D1E), P dpy-30 CNT-1b(D1E), P dpy-30 tCNT-1a, P dpy-30 tCNT-1b, P dpy-30 CNT-1 F2, P dpy-30 CNT-1 F3, P dpy-30 CNT-1a(K284A), and P dpy-30 tCNT-1a(K284A) were injected into cnt-1(tm2313) animals at 20 µg/ml along with the pTG96 plasmid (at 20 µg/ml). Transgenic arrays containing P dpy-30 tCNT-1a were then crossed into the akt-1(mg144gf), age-1(mg44) or daf-16(mu86) mutant for further analyses. P sur-5 AKT-1-PHøGFP was injected into daf-18(e1375) animals at 20 µg/ml along with the pRF4 (at 20 µg/ml), a dominant rol-6 construct. One of the transgenic arrays was then crossed into N2 animals and smIs82; daf-18(e1375) animals or injected with P dpy-30 tCNT-1a at 20 µg/ml along with P sur-5 mCherry (at 20 µg/ml) as the second transgenic marker to generate transgenic animals containing both P dpy-30 tCNT-1a and P sur-5 AKT-1-PHøGFP. P dpy-30 AKT-1, P dpy-30 AKT-1(K222M), P dpy-30 AKT-2, or P dpy-30 AKT-2(K209M) was injected into akt-1(tm399)/nT1; akt-2(tm1075) animals at 20 µg/ml along with the pTG96 plasmid (at 20 µg/ml).
Molecular biology.
Full-length cnt-1a cDNA and cnt-1b cDNA were amplified with reverse-transcription PCR (RT-PCR) and then subcloned into the pET-41b vector via its SpeI and NotI sites to generate the pET-41b-CNT-1a and pET-41b-CNT-1b expression vector. For the various pET-41b-CNT-1mutant expression vectors (pET-41b-CNT-1a(D1E), pET-41b-CNT-1a(D2E), pET-41b-CNT-1a(D3E), pET-41b-CNT-1b(D1E), pET-41b-CNT-1b(D2E), pET-41b-CNT-1b(D3E), and pET-41b-CNT-1a(K284A)), pET-41b-CNT-1a or pET-41b-CNT-1b was used as a DNA template to make the indicated amino acid substitutions with a QuikChange mutagenesis kit (Stratagene).
